Producer of plant-based egg products intended to offer a healthy, animal-friendly and nutritional food alternative.
Producer of plant-based egg products intended to offer a healthy, animal-friendly and nutritional food alternative.
Food Products📍 Alameda, CAFounded 2011
Current Valuation
$2.6B
as of 2022-Q3
UNICORN
QL Price
$2.6B
0% vs last round
QuantLogix's current estimate for Eat Just, published 2026-09-07 — in line with the last disclosed round of $2.6B (2022-Q3).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$2.6B
2022-Q3
weight 0.07
Secondary market print
$2.6B
2026-06-27
weight 0.65
How this price has held up
No round has priced for Eat Just since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-07 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Eat Just, 2026-09-07 (063dca5e1ecd28c1).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Eat Just going public?
No. Eat Just is private and has not filed to go public. There is no S-1 on file.
What is Eat Just's valuation in 2026?
Eat Just is valued at $2.6B as of 2022-Q3, set by its Series F ($25M, Aug 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Eat Just filed an S-1?
No public S-1 is on file for Eat Just.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2011
HQ
Alameda, CA
Employees
308
Total Raised
$864.53M
Last Round
Series F — $25M (Aug 2022)
IPO Status
private
Fundraising Status
Series F · $25M · 4y 1mo ago
privateTotal raised $864.53M
Secondary Market
Implied price / share
$4.27
Open interest
4
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
$25M
Aug 2022
—
$2.6B
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Eat Just — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-03. Re-checked weekly.
Talent Signal
Hiring trend
▲ Hiring uptrend
100% of roles posted in last 30d
Open roles
2
via greenhouse
Product-build share
0%
engineering, research, product, design
Trajectory
expanding
go-to-market push — Only 0% of open roles build product — hiring is concentrated in sales/marketing/ops (1 of 2 open roles are other).
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Director, Food Safety & QualityMarketing Director
Counted from Eat Just's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Food ProcessingBiotechnologyFood and BeverageNutritionOrganic Food
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q3. Refreshed quarterly.